I-CAS 163521-08-2 Purity >99.0% (HPLC) API High Purity

Incazelo emfushane:

CAS: 1761-61-1

Ubumsulwa: >99.0% (HPLC)

Ukubukeka: Impushana Emhlophe noma Engamhlophe

I-5-HT1A I-Agonist Eyingxenye kanye ne-SSRI enamandla;I-Antidepressant

Ikhwalithi ephezulu ye-API, Ukukhiqiza Kwezentengiso

E-Mail: alvin@ruifuchem.com

Thumela i-imeyili kithi

Imininingwane Yomkhiqizo

Imikhiqizo Ehlobene

Omaka bomkhiqizo

Incazelo:

IziMphakathi Ezihlobene Nokuhlinzeka Ngomkhiqizi
5-Cyanoindole CAS 15861-24-2
3-(4-Chlorobutyl)-5-Cyanoindole CAS 143612-79-7
I-Ethyl 5-Nitrobenzofuran-2-Carboxylate CAS 69604-00-8
I-Ethyl 5-Aminobenzofuran-2-Carboxylate CAS 174775-48-5
5-(Piperazin-1-yl)benzofuran-2-Carboxamide CAS 183288-46-2
I-CAS 163521-08-2

Chemical Properties:

Omqondofana	5-[4-[4-(5-Cyanoindol-3-yl)butyl]piperazin-1-yl]benzofuran-2-Carboxamide Hydrochloride
Inombolo ye-CAS	1761-61-1
Isimo Sesitoko	Esitokweni, Isikali Sokukhiqiza Sifinyelela Kumathani
I-Molecular Formula	I-C26H28ClN5O2
Isisindo samangqamuzana	477.98582
I-Melting Point	279℃ (okhanyayo)
Ibhrendi	I-Ruifu Chemical

Imininingwane:

Into	Imininingwane
Ukubukeka	Impushana Emhlophe noma Engamhlophe
Ukuhlonza	Nge-IR;Nge-HPLC
Okuqukethwe Amanzi	<1.00%
Izinsalela Ekushiseni	<0.10%
Izinsimbi Ezisindayo	<20ppm
Izinto Ezihlobene
Noma Ikuphi Ukungcola Okukodwa	<0.50%
Ukungcola Okuphelele	<1.00%
Ukuhlanzeka / Indlela Yokuhlaziya	>99.0% (HPLC) (kwisisekelo esingenamanzi)
Izinga Lokuhlola	I-Enterprise Standard
Ukusetshenziswa	I-API;Ukwelashwa kwe-Major Depressive Disorder (MDD);I-Antidepressant

Iphakheji nesitoreji:

Iphakheji: Ibhodlela, isikhwama se-Aluminium foil, 25kg/Cardboard Drum, noma ngokwemfuneko yekhasimende

Isimo Sesitoreji:Gcina ezitsheni ezivaliwe endaweni epholile neyomile;Vikela ekukhanyeni nakumswakama

Izinzuzo:

I-FAQ:

Isicelo:

I-API (i-CAS: 163521-08-2) iyinhlanganisela ye-serotonin ethize reuptake inhibitor (SSRI) kanye ne-5-HT1A ye-receptor partial agonist yokwelashwa kwe-Major Depressive Disorder (MDD).I-Antidepressant.Imakethwa ngaphansi kwegama lokuhweba elithi Viibryd, yathuthukiswa i-Merck KGaA (Germany) futhi yagunyazwa ukwelashwa kokudangala yi-US FDA ngoJanuwari 21, 2011. Iboniswe ukuthi ibekezelelwa kahle emazingeni emithamo aphezulu, ikakhulukazi kungabangeli ukukhuluphala okuphawulekayo noma ukuncipha kwesifiso socansi noma ukusebenza, okuwukuthuthukiswa ngaphezu kwemithi ekhona yokudambisa ukucindezeleka.I-Shanghai Ruifu Chemical Co., Ltd. ingumkhiqizi ohamba phambili nomphakeli wayo kanye nabaxhumanisi abahlobene abanekhwalithi ephezulu.